Loading…
Influence of the in situ component in 389 infiltrating ductal breast carcinomas
Background Our aim was to evaluate and compare lymph node involvement, as well as disease-free survival (DFS) and overall survival (OS), between infiltrating ductal carcinoma with (group 1) and without (group 2) intraductal carcinoma component in order to determine the prognostic value of the intrad...
Saved in:
| Published in: | Breast cancer (Tokyo, Japan) Japan), 2013-07, Vol.20 (3), p.213-217 |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c464t-5e0ce7465fdb31d39ed62c2929390e13bd1324c3b5cfb0301f6c79ab232144f13 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c464t-5e0ce7465fdb31d39ed62c2929390e13bd1324c3b5cfb0301f6c79ab232144f13 |
| container_end_page | 217 |
| container_issue | 3 |
| container_start_page | 213 |
| container_title | Breast cancer (Tokyo, Japan) |
| container_volume | 20 |
| creator | Carabias-Meseguer, Pau Zapardiel, Ignacio Cusidó-Gimferrer, Maite Godoy-Tundidor, Sonia Tresserra-Casas, Francesc Rodriguez-García, Ignacio Fábregas-Xauradó, Rafael Xercavins-Montosa, Jordi |
| description | Background
Our aim was to evaluate and compare lymph node involvement, as well as disease-free survival (DFS) and overall survival (OS), between infiltrating ductal carcinoma with (group 1) and without (group 2) intraductal carcinoma component in order to determine the prognostic value of the intraductal component.
Methods
Data from 389 cases of infiltrating ductal carcinoma of the breast were included in the study by means of reviewing medical charts and pathology slides.
Results
There was no statistically significant difference between both groups regarding node status. The 5-year DFS rate was 90.7% in group 1 and 81.8% in group 2 (
p
= 0.014), with a median follow-up of 73.2 months (95% CI 68.3–77.4). There was no statistically significant difference in 5-year OS between groups (98% group 1 vs. 93% group 2) with a median global survival of 134 months (95% CI 131–137).
Conclusions
The presence of intraductal component in the infiltrating carcinoma seems to increase DFS and may be an independent and favorable prognostic factor for breast cancer. |
| doi_str_mv | 10.1007/s12282-011-0330-1 |
| format | article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1398422743</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A712277006</galeid><sourcerecordid>A712277006</sourcerecordid><originalsourceid>FETCH-LOGICAL-c464t-5e0ce7465fdb31d39ed62c2929390e13bd1324c3b5cfb0301f6c79ab232144f13</originalsourceid><addsrcrecordid>eNp9kU-L1jAQxoMo7h_9AF6k4MVL10kmb9Iel2V1Fxb2oueQppPXLm3ymqQHv70pXQVBJIcJyW-GeZ6HsXccrjiA_pS5EJ1ogfMWEKHlL9g57zpopUB8We8ooVWd6s7YRc5PABI1qNfsTAihOSh9zh7vg59XCo6a6JvynZopNHkqa-PicoqBQtlesOtr8dNcki1TODbj6oqdmyGRzaVxNrkpxMXmN-yVt3Omt8_1kn37fPv15q59ePxyf3P90DqpZGkPBI60VAc_DshH7GlUwole9NgDcRxGjkI6HA7OD4DAvXK6t4NAwaX0HC_Zx33uKcUfK-Vilik7mmcbKK7ZcOw7WVVKrOiHHT3amUxVEasIt-HmWlcHtQZQlbr6B1XPSMvkqhFVPP3dwPcGl2LOibw5pWmx6afhYLZ4zB6PqfGYLR6zbf3-eet1WGj80_E7jwqIHcj1Kxwpmae4plCd_M_UX-QIl6g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1398422743</pqid></control><display><type>article</type><title>Influence of the in situ component in 389 infiltrating ductal breast carcinomas</title><source>Springer Link</source><creator>Carabias-Meseguer, Pau ; Zapardiel, Ignacio ; Cusidó-Gimferrer, Maite ; Godoy-Tundidor, Sonia ; Tresserra-Casas, Francesc ; Rodriguez-García, Ignacio ; Fábregas-Xauradó, Rafael ; Xercavins-Montosa, Jordi</creator><creatorcontrib>Carabias-Meseguer, Pau ; Zapardiel, Ignacio ; Cusidó-Gimferrer, Maite ; Godoy-Tundidor, Sonia ; Tresserra-Casas, Francesc ; Rodriguez-García, Ignacio ; Fábregas-Xauradó, Rafael ; Xercavins-Montosa, Jordi</creatorcontrib><description>Background
Our aim was to evaluate and compare lymph node involvement, as well as disease-free survival (DFS) and overall survival (OS), between infiltrating ductal carcinoma with (group 1) and without (group 2) intraductal carcinoma component in order to determine the prognostic value of the intraductal component.
Methods
Data from 389 cases of infiltrating ductal carcinoma of the breast were included in the study by means of reviewing medical charts and pathology slides.
Results
There was no statistically significant difference between both groups regarding node status. The 5-year DFS rate was 90.7% in group 1 and 81.8% in group 2 (
p
= 0.014), with a median follow-up of 73.2 months (95% CI 68.3–77.4). There was no statistically significant difference in 5-year OS between groups (98% group 1 vs. 93% group 2) with a median global survival of 134 months (95% CI 131–137).
Conclusions
The presence of intraductal component in the infiltrating carcinoma seems to increase DFS and may be an independent and favorable prognostic factor for breast cancer.</description><identifier>ISSN: 1340-6868</identifier><identifier>EISSN: 1880-4233</identifier><identifier>DOI: 10.1007/s12282-011-0330-1</identifier><identifier>PMID: 22271067</identifier><language>eng</language><publisher>Tokyo: Springer Japan</publisher><subject>Breast Neoplasms - mortality ; Breast Neoplasms - pathology ; Cancer Research ; Carcinoma, Ductal, Breast - mortality ; Carcinoma, Ductal, Breast - pathology ; Carcinoma, Intraductal, Noninfiltrating - mortality ; Carcinoma, Intraductal, Noninfiltrating - pathology ; Female ; Humans ; Lymph Nodes - pathology ; Medicine ; Medicine & Public Health ; Middle Aged ; Neoplasm Grading ; Oncology ; Original Article ; Prognosis ; Surgery ; Surgical Oncology ; Survival Rate</subject><ispartof>Breast cancer (Tokyo, Japan), 2013-07, Vol.20 (3), p.213-217</ispartof><rights>The Japanese Breast Cancer Society 2012</rights><rights>COPYRIGHT 2013 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c464t-5e0ce7465fdb31d39ed62c2929390e13bd1324c3b5cfb0301f6c79ab232144f13</citedby><cites>FETCH-LOGICAL-c464t-5e0ce7465fdb31d39ed62c2929390e13bd1324c3b5cfb0301f6c79ab232144f13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22271067$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Carabias-Meseguer, Pau</creatorcontrib><creatorcontrib>Zapardiel, Ignacio</creatorcontrib><creatorcontrib>Cusidó-Gimferrer, Maite</creatorcontrib><creatorcontrib>Godoy-Tundidor, Sonia</creatorcontrib><creatorcontrib>Tresserra-Casas, Francesc</creatorcontrib><creatorcontrib>Rodriguez-García, Ignacio</creatorcontrib><creatorcontrib>Fábregas-Xauradó, Rafael</creatorcontrib><creatorcontrib>Xercavins-Montosa, Jordi</creatorcontrib><title>Influence of the in situ component in 389 infiltrating ductal breast carcinomas</title><title>Breast cancer (Tokyo, Japan)</title><addtitle>Breast Cancer</addtitle><addtitle>Breast Cancer</addtitle><description>Background
Our aim was to evaluate and compare lymph node involvement, as well as disease-free survival (DFS) and overall survival (OS), between infiltrating ductal carcinoma with (group 1) and without (group 2) intraductal carcinoma component in order to determine the prognostic value of the intraductal component.
Methods
Data from 389 cases of infiltrating ductal carcinoma of the breast were included in the study by means of reviewing medical charts and pathology slides.
Results
There was no statistically significant difference between both groups regarding node status. The 5-year DFS rate was 90.7% in group 1 and 81.8% in group 2 (
p
= 0.014), with a median follow-up of 73.2 months (95% CI 68.3–77.4). There was no statistically significant difference in 5-year OS between groups (98% group 1 vs. 93% group 2) with a median global survival of 134 months (95% CI 131–137).
Conclusions
The presence of intraductal component in the infiltrating carcinoma seems to increase DFS and may be an independent and favorable prognostic factor for breast cancer.</description><subject>Breast Neoplasms - mortality</subject><subject>Breast Neoplasms - pathology</subject><subject>Cancer Research</subject><subject>Carcinoma, Ductal, Breast - mortality</subject><subject>Carcinoma, Ductal, Breast - pathology</subject><subject>Carcinoma, Intraductal, Noninfiltrating - mortality</subject><subject>Carcinoma, Intraductal, Noninfiltrating - pathology</subject><subject>Female</subject><subject>Humans</subject><subject>Lymph Nodes - pathology</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Neoplasm Grading</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Prognosis</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><subject>Survival Rate</subject><issn>1340-6868</issn><issn>1880-4233</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNp9kU-L1jAQxoMo7h_9AF6k4MVL10kmb9Iel2V1Fxb2oueQppPXLm3ymqQHv70pXQVBJIcJyW-GeZ6HsXccrjiA_pS5EJ1ogfMWEKHlL9g57zpopUB8We8ooVWd6s7YRc5PABI1qNfsTAihOSh9zh7vg59XCo6a6JvynZopNHkqa-PicoqBQtlesOtr8dNcki1TODbj6oqdmyGRzaVxNrkpxMXmN-yVt3Omt8_1kn37fPv15q59ePxyf3P90DqpZGkPBI60VAc_DshH7GlUwole9NgDcRxGjkI6HA7OD4DAvXK6t4NAwaX0HC_Zx33uKcUfK-Vilik7mmcbKK7ZcOw7WVVKrOiHHT3amUxVEasIt-HmWlcHtQZQlbr6B1XPSMvkqhFVPP3dwPcGl2LOibw5pWmx6afhYLZ4zB6PqfGYLR6zbf3-eet1WGj80_E7jwqIHcj1Kxwpmae4plCd_M_UX-QIl6g</recordid><startdate>20130701</startdate><enddate>20130701</enddate><creator>Carabias-Meseguer, Pau</creator><creator>Zapardiel, Ignacio</creator><creator>Cusidó-Gimferrer, Maite</creator><creator>Godoy-Tundidor, Sonia</creator><creator>Tresserra-Casas, Francesc</creator><creator>Rodriguez-García, Ignacio</creator><creator>Fábregas-Xauradó, Rafael</creator><creator>Xercavins-Montosa, Jordi</creator><general>Springer Japan</general><general>Springer</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20130701</creationdate><title>Influence of the in situ component in 389 infiltrating ductal breast carcinomas</title><author>Carabias-Meseguer, Pau ; Zapardiel, Ignacio ; Cusidó-Gimferrer, Maite ; Godoy-Tundidor, Sonia ; Tresserra-Casas, Francesc ; Rodriguez-García, Ignacio ; Fábregas-Xauradó, Rafael ; Xercavins-Montosa, Jordi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c464t-5e0ce7465fdb31d39ed62c2929390e13bd1324c3b5cfb0301f6c79ab232144f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Breast Neoplasms - mortality</topic><topic>Breast Neoplasms - pathology</topic><topic>Cancer Research</topic><topic>Carcinoma, Ductal, Breast - mortality</topic><topic>Carcinoma, Ductal, Breast - pathology</topic><topic>Carcinoma, Intraductal, Noninfiltrating - mortality</topic><topic>Carcinoma, Intraductal, Noninfiltrating - pathology</topic><topic>Female</topic><topic>Humans</topic><topic>Lymph Nodes - pathology</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Neoplasm Grading</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Prognosis</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><topic>Survival Rate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Carabias-Meseguer, Pau</creatorcontrib><creatorcontrib>Zapardiel, Ignacio</creatorcontrib><creatorcontrib>Cusidó-Gimferrer, Maite</creatorcontrib><creatorcontrib>Godoy-Tundidor, Sonia</creatorcontrib><creatorcontrib>Tresserra-Casas, Francesc</creatorcontrib><creatorcontrib>Rodriguez-García, Ignacio</creatorcontrib><creatorcontrib>Fábregas-Xauradó, Rafael</creatorcontrib><creatorcontrib>Xercavins-Montosa, Jordi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Breast cancer (Tokyo, Japan)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Carabias-Meseguer, Pau</au><au>Zapardiel, Ignacio</au><au>Cusidó-Gimferrer, Maite</au><au>Godoy-Tundidor, Sonia</au><au>Tresserra-Casas, Francesc</au><au>Rodriguez-García, Ignacio</au><au>Fábregas-Xauradó, Rafael</au><au>Xercavins-Montosa, Jordi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Influence of the in situ component in 389 infiltrating ductal breast carcinomas</atitle><jtitle>Breast cancer (Tokyo, Japan)</jtitle><stitle>Breast Cancer</stitle><addtitle>Breast Cancer</addtitle><date>2013-07-01</date><risdate>2013</risdate><volume>20</volume><issue>3</issue><spage>213</spage><epage>217</epage><pages>213-217</pages><issn>1340-6868</issn><eissn>1880-4233</eissn><abstract>Background
Our aim was to evaluate and compare lymph node involvement, as well as disease-free survival (DFS) and overall survival (OS), between infiltrating ductal carcinoma with (group 1) and without (group 2) intraductal carcinoma component in order to determine the prognostic value of the intraductal component.
Methods
Data from 389 cases of infiltrating ductal carcinoma of the breast were included in the study by means of reviewing medical charts and pathology slides.
Results
There was no statistically significant difference between both groups regarding node status. The 5-year DFS rate was 90.7% in group 1 and 81.8% in group 2 (
p
= 0.014), with a median follow-up of 73.2 months (95% CI 68.3–77.4). There was no statistically significant difference in 5-year OS between groups (98% group 1 vs. 93% group 2) with a median global survival of 134 months (95% CI 131–137).
Conclusions
The presence of intraductal component in the infiltrating carcinoma seems to increase DFS and may be an independent and favorable prognostic factor for breast cancer.</abstract><cop>Tokyo</cop><pub>Springer Japan</pub><pmid>22271067</pmid><doi>10.1007/s12282-011-0330-1</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1340-6868 |
| ispartof | Breast cancer (Tokyo, Japan), 2013-07, Vol.20 (3), p.213-217 |
| issn | 1340-6868 1880-4233 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1398422743 |
| source | Springer Link |
| subjects | Breast Neoplasms - mortality Breast Neoplasms - pathology Cancer Research Carcinoma, Ductal, Breast - mortality Carcinoma, Ductal, Breast - pathology Carcinoma, Intraductal, Noninfiltrating - mortality Carcinoma, Intraductal, Noninfiltrating - pathology Female Humans Lymph Nodes - pathology Medicine Medicine & Public Health Middle Aged Neoplasm Grading Oncology Original Article Prognosis Surgery Surgical Oncology Survival Rate |
| title | Influence of the in situ component in 389 infiltrating ductal breast carcinomas |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T13%3A20%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Influence%20of%20the%20in%20situ%20component%20in%20389%20infiltrating%20ductal%20breast%20carcinomas&rft.jtitle=Breast%20cancer%20(Tokyo,%20Japan)&rft.au=Carabias-Meseguer,%20Pau&rft.date=2013-07-01&rft.volume=20&rft.issue=3&rft.spage=213&rft.epage=217&rft.pages=213-217&rft.issn=1340-6868&rft.eissn=1880-4233&rft_id=info:doi/10.1007/s12282-011-0330-1&rft_dat=%3Cgale_proqu%3EA712277006%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c464t-5e0ce7465fdb31d39ed62c2929390e13bd1324c3b5cfb0301f6c79ab232144f13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1398422743&rft_id=info:pmid/22271067&rft_galeid=A712277006&rfr_iscdi=true |